Skip to main content

Advertisement

SpringerLink
Log in

Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203

  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

Abstract

Chemotherapeutic resistance is the main reason of the failure in clinical treatment of gastric cancer. Berberine (BER) is the active compound of traditional Chinese medicine Huang Lian. The aim of this present study is to evaluate the effect of BER on cisplatin resistance in gastric cancer cells and to investigate its possible mechanism. Gastric cancer cell lines SGC-7901 and BGC-823 and their respective cisplatin-resistant variants SGC-7901/DDP and BGC-823/DDP were used in this study. We found that BER treatment significantly reversed cisplatin sensitivity and induced caspase-dependent apoptosis in SGC-7901/DDP and BGC-823/DDP cells; BER treatment induced miR-203 expression, and overexpression of miR-203 mimicked the cisplatin-sensitizing effect of BER. Importantly, we showed that miR-203 was able to target the 3′UTR of Bcl-w. Therefore, we conclude that BER treatment reduces cisplatin resistance of gastric cancer cells by modulating the miR-203/Bcl-w apoptotic axis. BER may be a novel agent to enhance chemotherapeutic responses in cisplatin-resistant gastric cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1.
Figure 2.
Figure 3.
Figure 4.

Similar content being viewed by others

References

  • Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297

    Article  CAS  PubMed  Google Scholar 

  • Chang, W., Chen, L., and Hatch, G.M. (2014). Berberine as a therapy for type 2 diabetes and its complications: from mechanism of action to clinical studies. Biochem Cell Biol, 1–8.

  • Chen Q, Qin R, Fang Y, Li H (2015) Berberine sensitizes human ovarian cancer cells to cisplatin through miR-93/PTEN/Akt signaling pathway. Cell Physiol Biochem 36:956–965

    Article  CAS  PubMed  Google Scholar 

  • Chiang Y, Song Y, Wang Z, Chen Y, Yue Z, Xu H, Xing C, Liu Z (2011) Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. J Gastrointest Surg 15:63–70

    Article  PubMed  Google Scholar 

  • Hu HY, Li KP, Wang XJ, Liu Y, Lu ZG, Dong RH, Guo HB, Zhang MX (2013) Set9, NF-kappaB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells. Acta Pharmacol Sin 34:157–166

    Article  PubMed  Google Scholar 

  • Imaoka, H., Toiyama, Y., Okigami, M., Yasuda, H., Saigusa, S., Ohi, M., Tanaka, K., Inoue, Y., Mohri, Y., and Kusunoki, M. (2015). Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer. Gastric Cancer

  • Li XK, Motwani M, Tong W, Bornmann W, Schwartz GK (2000) Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol Pharmacol 58:1287–1293

    CAS  PubMed  Google Scholar 

  • Li DX, Zhang J, Zhang Y, Zhao PW, Yang LM (2015) Inhibitory effect of berberine on human skin squamous cell carcinoma A431 cells. Genet Mol Res 14:10553–10568

    Article  CAS  PubMed  Google Scholar 

  • Lin JP, Yang JS, Lee JH, Hsieh WT, Chung JG (2006) Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol 12:21–28

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lin JP, Yang JS, Wu CC, Lin SS, Hsieh WT, Lin ML, Yu FS, Yu CS, Chen GW, Chang YH et al (2008) Berberine induced down-regulation of matrix metalloproteinase-1, −2 and −9 in human gastric cancer cells (SNU-5) in vitro. In Vivo 22:223–230

    CAS  PubMed  Google Scholar 

  • Liu S, Fang Y, Shen H, Xu W, Li H (2013) Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis. Acta Biochim Biophys Sin Shanghai 45:756–762

    Article  CAS  PubMed  Google Scholar 

  • McKenna DJ, McDade SS, Patel D, McCance DJ (2010) MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J Virol 84:10644–10652

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ortiz LM, Lombardi P, Tillhon M, Scovassi AI (2014) Berberine, an epiphany against cancer. Molecules 19:12349–12367

    Article  PubMed  Google Scholar 

  • Pandey A, Vishnoi K, Mahata S, Tripathi SC, Misra SP, Misra V, Mehrotra R, Dwivedi M, Bharti AC (2015) Berberine and curcumin target survivin and STAT3 in gastric cancer cells and synergize actions of standard chemotherapeutic 5-fluorouracil. Nutr Cancer 67:1293–1304

    Article  PubMed  Google Scholar 

  • Pasquinelli AE (2012) MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13:271–282

    CAS  PubMed  Google Scholar 

  • Shi, Y., Tan, Y.J., Zeng, D.Z., Qian, F., and Yu, P.W. (2015). miR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis. Tumour Biol

  • Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265–7279

    Article  CAS  PubMed  Google Scholar 

  • Tang J, Li L, Huang W, Sui C, Yang Y, Lin X, Hou G, Chen X, Fu J, Yuan S et al (2015) MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition. Cancer Lett 364:33–43

    Article  CAS  PubMed  Google Scholar 

  • Wan X, Ding X, Chen S, Song H, Jiang H, Fang Y, Li P, Guo J (2015) The functional sites of miRNAs and lncRNAs in gastric carcinogenesis. Tumour Biol 36:521–532

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang J, Peng Y, Liu Y, Yang J, Ding N, Tan W (2015a) Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth. BMC Cancer 15:595

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang N, Tan HY, Li L, Yuen MF, Feng Y (2015b) Berberine and Coptidis Rhizoma as potential anticancer agents: recent updates and future perspectives. J Ethnopharmacol 176:35–48

    Article  CAS  PubMed  Google Scholar 

  • Wang N, Zhu M, Tsao SW, Man K, Zhang Z, Feng Y (2013) MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma. Mol Cancer 12:119

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang N, Zhu M, Wang X, Tan HY, Tsao SW, Feng Y (2014) Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma. Biochim Biophys Acta 1839:849–857

    Article  CAS  PubMed  Google Scholar 

  • Yi T, Zhuang L, Song G, Zhang B, Li G, Hu T (2015) Akt signaling is associated with the berberine-induced apoptosis of human gastric cancer cells. Nutr Cancer 67:523–531

    Article  CAS  PubMed  Google Scholar 

  • Yu YN, Yu TC, Zhao HJ, Sun TT, Chen HM, Chen HY, An HF, Weng YR, Yu J, Li M et al (2015) Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget 6:32013–32026

    PubMed  PubMed Central  Google Scholar 

  • Zhang X, Zhang Y, Liu X, Fang A, Li P, Li Z, Liu T, Yang Y, Du L, Wang C (2015) MicroRNA-203 is a prognostic indicator in bladder cancer and enhances chemosensitivity to cisplatin via apoptosis by targeting Bcl-w and survivin. PLoS ONE 10, e0143441

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhou X, Xu G, Yin C, Jin W, Zhang G (2014) Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK. Oncotarget 5:11631–11640

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhu T, Li LL, Xiao GF, Luo QZ, Liu QZ, Yao KT, Xiao GH (2015) Berberine increases doxorubicin sensitivity by suppressing STAT3 in lung cancer. Am J Chin Med 43:1487–1502

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laparoscopic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China

    He-Yi You, Xue-Meng Xie, Wei-Jian Zhang, Heng-Liang Zhu & Fei-Zhao Jiang

Authors
  1. He-Yi You
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xue-Meng Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei-Jian Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heng-Liang Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fei-Zhao Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to He-Yi You.

Additional information

Editor: Tetsuji Okamoto

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

You, HY., Xie, XM., Zhang, WJ. et al. Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203. In Vitro Cell.Dev.Biol.-Animal 52, 857–863 (2016). https://doi.org/10.1007/s11626-016-0044-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11626-016-0044-y

Keywords

Search

Navigation